Why You Should Count On Cortexyme To Deliver The Alzheimer’s Drug! $CRTX

Jitters of The Biotech Investors and Their Cure In most PRs companies give some measure of improvement of patients, with the number of subject and the p-values. The certainty of the improvemnts are judged mostely throught the prism of p-values as it is a number with a threshold once attained a semblence of certainty is … Continue reading Why You Should Count On Cortexyme To Deliver The Alzheimer’s Drug! $CRTX

Alzheimer’s, Due to Fatal Infection? Cortexyme vs. Annovis Bio $CRTX $ANVS

The question is a simple one. Is Alzheimer's a disease or a syndrome?. If it is a disease then it shall have one particular etiology with one drug to it. Of course, this is a great exaggeration but serves its purpose of illustration the difference between a disease and a syndrome, which is a set of symptoms that can have varied etiology. Talking more in terms of game theory, investing in Alzheimer's drugs can be zero sum game or game where many are going to be winners, although fractionally